{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:49:35Z","timestamp":1791049775509,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.fpc.0000182779.03180.ba","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T13:52:36Z","timestamp":1236174756000},"page":"59-71","source":"Crossref","is-referenced-by-count":37,"title":["Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations"],"prefix":"10.1097","volume":"16","author":[{"given":"Markus","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Toliat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landry K.","family":"Kamdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Brockm\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M.","family":"Zanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wojnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene** Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"R2-8-20210212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg999","article-title":"Signatures of natural selection in the human genome","volume":"4","author":"Bamshad","year":"2003","journal-title":"Nat Rev Genet"},{"key":"R3-8-20210212","first-page":"223","article-title":"Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio","volume":"47","author":"Kinirons","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/clpt.1993.199","article-title":"Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men","volume":"54","author":"Kinirons","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R5-8-20210212","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02353475","article-title":"Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans","volume":"24","author":"Wilkinson","year":"1996","journal-title":"J Pharmacokinet Biopharm"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","article-title":"Sex is a major determinant of CYP3A4 expression in human liver","volume":"38","author":"Wolbold","year":"2003","journal-title":"Hepatology"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0022-3565(25)12474-9","article-title":"Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues","volume":"253","author":"de Waziers","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-8-20210212","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00008571-200007000-00001","article-title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method","volume":"10","author":"Ozdemir","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00007691-200404000-00019","article-title":"Genetics of the variable expression of CYP3A in humans","volume":"26","author":"Wojnowski","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R13-8-20210212","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnci\/90.16.1225","article-title":"Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"90","author":"Rebbeck","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R14-8-20210212","first-page":"653","article-title":"CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia","volume":"9","author":"Tayeb","year":"2002","journal-title":"Oncol Rep"},{"key":"R15-8-20210212","first-page":"901","article-title":"Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients","volume":"8","author":"Paris","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-8-20210212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mcp.2002.121371","article-title":"CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity","volume":"71","author":"Garcia-Martin","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R17-8-20210212","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/jnci\/91.18.1587","article-title":"Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"91","author":"Ando","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R18-8-20210212","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00008571-200203000-00006","article-title":"Common allelic variants of cytochrome P4503A4 and their prevalence in different populations","volume":"12","author":"Lamba","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R19-8-20210212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bbrc.1999.0752","article-title":"Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5\u2032-upstream regulatory region","volume":"259","author":"Westlind","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R20-8-20210212","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/jnci\/91.18.1588","article-title":"Response: Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"91","author":"Amirimani","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008571-200207000-00003","article-title":"The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer","volume":"12","author":"Spurdle","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/94.8.630","article-title":"Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"94","author":"Wojnowski","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R23-8-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R25-8-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.31.6.755","article-title":"Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism","volume":"31","author":"Westlind-Johnsson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00210-004-0944-3","article-title":"Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone","volume":"370","author":"Kamdem","year":"2004","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"R27-8-20210212","first-page":"928","article-title":"CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer","volume":"12","author":"Plummer","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1158\/0008-5472.CAN-04-1651","article-title":"CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer","volume":"64","author":"Zeigler-Johnson","year":"2004","journal-title":"Cancer Res"},{"key":"R29-8-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00008571-200103000-00002","article-title":"Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene","volume":"11","author":"Gellner","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R30-8-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1034\/j.1600-6143.2003.00077.x","article-title":"Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms","volume":"3","author":"Zheng","year":"2003","journal-title":"Am J Transplant"},{"key":"R31-8-20210212","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"},{"key":"R32-8-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clpt.2004.11.003","article-title":"Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers","volume":"77","author":"Rodriguez-Antona","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R33-8-20210212","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/426406","article-title":"CYP3A variation and the evolution of salt-sensitivity variants","volume":"75","author":"Thompson","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R34-8-20210212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/humu.9210","article-title":"Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population","volume":"23","author":"Fukushima-Uesaka","year":"2004","journal-title":"Hum Mutat"},{"key":"R35-8-20210212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00008571-200410000-00007","article-title":"Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa","volume":"14","author":"Wojnowski","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R36-8-20210212","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg865","article-title":"Genetic analysis of African populations: human evolution and complex disease","volume":"3","author":"Tishkoff","year":"2002","journal-title":"Nat Rev Genet"},{"key":"R37-8-20210212","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/421051","article-title":"Genetic signatures of strong recent positive selection at the lactase gene","volume":"74","author":"Bersaglieri","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R38-8-20210212","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature01140","article-title":"Detecting recent positive selection in the human genome from haplotype structure","volume":"419","author":"Sabeti","year":"2002","journal-title":"Nature"},{"key":"R39-8-20210212","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.30.10.1108","article-title":"Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA","volume":"30","author":"Koch","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R40-8-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R41-8-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R42-8-20210212","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","article-title":"A comparison of bayesian methods for haplotype reconstruction from population genotype data","volume":"73","author":"Stephens","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R43-8-20210212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.molbev.a026036","article-title":"Median-joining networks for inferring intraspecific phylogenies","volume":"16","author":"Bandelt","year":"1999","journal-title":"Mol Biol Evol"},{"key":"R44-8-20210212","article-title":"Principles of Population Genetics","author":"Hartl","year":"1997"},{"key":"R45-8-20210212","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"R46-8-20210212","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/bbrc.1999.1233","article-title":"Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver","volume":"262","author":"Sumida","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R47-8-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00228-002-0487-9","article-title":"Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression","volume":"58","author":"Sy","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R48-8-20210212","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R49-8-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/907","article-title":"DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene","volume":"19","author":"Nickerson","year":"1998","journal-title":"Nat Genet"},{"key":"R50-8-20210212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.genom.5.061903.180021","article-title":"Africans and Asians abroad: genetic diversity in Europe","volume":"5","author":"Barbujani","year":"2004","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R51-8-20210212","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1101\/gr.631202","article-title":"Interrogating a high-density SNP map for signatures of natural selection","volume":"12","author":"Akey","year":"2002","journal-title":"Genome Res"},{"key":"R52-8-20210212","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1126\/science.1105436","article-title":"Whole-genome patterns of common DNA variation in three human populations","volume":"307","author":"Hinds","year":"2005","journal-title":"Science"},{"key":"R53-8-20210212","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jc.2004-0966","article-title":"CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis","volume":"90","author":"Gupta","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-8-20210212","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1359\/JBMR.0301257","article-title":"CYP3A4 is a human microsomal vitamin D 25-hydroxylase","volume":"19","author":"Gupta","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R55-8-20210212","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/clpt.1980.115","article-title":"Rifampicin and vitamin D metabolism","volume":"27","author":"Brodie","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"R56-8-20210212","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.60.6.1399","article-title":"Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D3","volume":"60","author":"Thummel","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R57-8-20210212","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI106868","article-title":"Phenobarbital-induced alterations in vitamin D metabolism","volume":"51","author":"Hahn","year":"1972","journal-title":"J Clin Invest"},{"key":"R58-8-20210212","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/0301446021000019144","article-title":"Sexual selection as a cause of human skin colour variation: Darwin's hypothesis revisited","volume":"29","author":"Aoki","year":"2002","journal-title":"Ann Hum Biol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000182779.03180.ba","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:22:43Z","timestamp":1738956163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200601000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000182779.03180.ba","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}